Zobrazeno 1 - 10
of 17
pro vyhledávání: '"M V, Vakhrusheva"'
Autor:
A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 12, Pp 86-96 (2017)
Aim. To assess the results of following up patients with chronic myeloid leukemia (CML) and a deep molecular response (MR) without tyrosine kinase inhibitor (TKI) therapy. Subjects and methods. The reasons for TKI discontinuation in 70 patients with
Externí odkaz:
https://doaj.org/article/a5d61a4d5cc34f2caccd0b415e5af767
Publikováno v:
Терапевтический архив, Vol 88, Iss 1, Pp 89-95 (2016)
Patients with myeloproliferative diseases (MPD) are noted to be at high risk for portal thromboses. This problem gives rise to disability if it is untimely treated or resistant to therapy. The paper gives the experience of the Outpatient Department o
Externí odkaz:
https://doaj.org/article/c39a8eeb2d024e029564869ef450ef47
Autor:
A L Melikian, I N Subortseva, S R Goriacheva, T I Kolosheĭnova, M V Vakhrusheva, A M Kovrigina, A B Sudarikov, V N Dvirnyk, T N Obukhova
Publikováno v:
Терапевтический архив, Vol 86, Iss 12, Pp 127-134 (2014)
The term mastocytosis (MC) encompasses a group of rare diseases characterized by the tumorous proliferation of clonal mast cells and the infiltration of one or several organs. The clinical picture of MC is extremely diverse from skin lesions that can
Externí odkaz:
https://doaj.org/article/e5078b08a1ec468b92897ee4ac3af83d
Autor:
O. Yu. Vinogradova, E. A. Aseeva, A. V. Vorontsova, A. G. Turkina, A. L. Neverova, O. V. Lazareva, E. Yu. Chelysheva, G. A. Gusarova, T. I. Kolosheinova, L. Yu. Kolosova, S. R. Goryacheva, M. V. Vakhrusheva, S. M. Kulikov, I. A. Tishchenko, L. V. Dyachenko, A. I. Udovichenko, G. A. Alimova, E. V. Kleina, L. A. Grebenyuk, M. L. Konnova, S. Yu. Smirnova, N. D. Khoroshko, E. V. Domracheva
Publikováno v:
Онкогематология, Vol 7, Iss 4, Pp 24-34 (2014)
The additional molecular and chromosomal abnormalities (ACA) in Phositive cells usually considered as a genetic marker of chronic myeloid leukemia (CML) progression. 457 patients in different CML phases received tyrosine kinase inhibitors (1st and 2n
Externí odkaz:
https://doaj.org/article/32cda5ba2fdf4d37889b2dd716f62b03
Autor:
A L Melikian, T I Kolosheĭnova, S R Goriacheva, I N Subortseva, M V Vakhrusheva, E N Kolosova, A B Sudarikov, A O Abdullaev, V N Dvirnyk, E Iu Varlamova, A M Kovrigina, A G Turkina
Publikováno v:
Терапевтический архив, Vol 86, Iss 7, Pp 37-44 (2014)
AIM. To determine the clinical features of multiple primary tumors (MPT) in patients with hemoblastoses, to develop treatment policy for synchronous and metachronous tumors, and to determine the impact of chemotherapy for one disease on the course an
Externí odkaz:
https://doaj.org/article/5f12c74511724a4182f454278733a615
Autor:
G A Gusarova, A G Turkina, E V Domracheva, L Yu Tikhonova, M O Egorova, T I Kolosheynova, O V Stakhina, I S Nemchenko, M V Vakhrusheva, E Yu Chelysheva, E S Zakharova, S R Goryacheva, M A Sokolova, S V Kuznetsov, N A Afanas'eva, N D Khoroshko
Publikováno v:
Современная онкология, Vol 12, Iss 1, Pp 38-42 (2010)
Externí odkaz:
https://doaj.org/article/2378899bf7fc419d80c98cdefa5a74c9
Autor:
Anna Grigor'evna Turkina, Elena Vasil'evna Domracheva, Aleksandra Valer'evna Vorontsova, Elena Aleksandrovna Aseeva, Ol'ga Yur'evna Vinogradova, Ol'ga Veniaminovna Stakhina, Galina Anatol'evna Gusarova, Ol'ga Arkad'evna Dyagileva, Elena Aleksandrovna Semenova, Marina Vasil'evna Vakhrusheva, Tamara Ivanovna Kolosheynova, Evgeniy Mikhaylovich Abakumov, Ekaterina Yur'evna Chelysheva, Svetlana Rudol'fovna Goryacheva, Tat'yana Vladimirovna Ivanova, Elena Stanislavovna Zakharova, Lyubov' Yur'evna Kolosova, Adel' Vladimirovna Zakharova, Irina Nikolaevna Naumova, Larisa Vladimirovna Dyachenko, Sergey Mikhaylovich Kulikov, Lidiya Grigor'evna Kovaleva, Nina Dmitrievna Khoroshko, A G Turkina, E V Domracheva, A V Vorontsova, E A Aseeva, O Yu Vinogradova, O V Stakhina, G A Gusarova, O A Dyagileva, E A Semenova, M V Vakhrusheva, T I Kolosheinova, E M Abakumov, E Yu Chelysheva, S R Goryacheva, T V Ivanova, E S Zakharova, L Yu Kolosova, A V Zakharova, I N Naumova, L V Dyachenko, S M Kulikov, L G Kovaleva, N D Khoroshko
Publikováno v:
Терапевтический архив, Vol 81, Iss 7, Pp 29-36 (2009)
Aim. To analyse clinical implications of chromosome 8 trisomy in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia (CML) treated with inhibitors of tyrosinkinases (ITK). Material and methods. A total of 386 patients with
Externí odkaz:
https://doaj.org/article/ede8cfd0b762457a94075ebaf7be705f
Publikováno v:
Antibiotiki. 22(8)
The data on the clinical trials of karminomycin, a new antitumor antibiotic are presented. The drug was used in the treatment of 46 adult patients with leukemia. Karminomycin was used in primary inducing therapy and treatment of relapses. The results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4af7da86eed00c54c84865fb08740af1
https://pubmed.ncbi.nlm.nih.gov/334058
https://pubmed.ncbi.nlm.nih.gov/334058
Autor:
L G, Kovaleva, M V, Vakhrusheva
Publikováno v:
Terapevticheskii arkhiv. 51(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e72aab235f0ae3b5de06b4b29d7f83be
https://pubmed.ncbi.nlm.nih.gov/494109
https://pubmed.ncbi.nlm.nih.gov/494109
Autor:
M V, Vakhrusheva, R M, Botova
Publikováno v:
Archives of pathologylaboratory medicine. 34(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4993f671f8204398d7ee054dfa017fc6
https://pubmed.ncbi.nlm.nih.gov/1044379
https://pubmed.ncbi.nlm.nih.gov/1044379